Bio-Rad Laboratories, Inc.
US ˙ NYSE ˙ US0905722072

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Bradford Crutchfield. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Bradford Crutchfield har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:TXG / 10x Genomics, Inc. Chief Commercial Officer 97.237
US:BIO / Bio-Rad Laboratories, Inc. Executive Vice President 0
US:NSTG / NanoString Technologies, Inc. Director 5.847
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Bradford Crutchfield. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb BIO / Bio-Rad Laboratories, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BIO / Bio-Rad Laboratories, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BIO / Bio-Rad Laboratories, Inc. Insider Trades
Insidersalg BIO / Bio-Rad Laboratories, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BIO / Bio-Rad Laboratories, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2012-09-10 BIO, BIOB CRUTCHFIELD BRADFORD 92 103,4905 92 103,4905 9.521 730 119.5400 1.477 15,51
2012-08-20 BIO, BIOB CRUTCHFIELD BRADFORD 4.000 103,1096 4.000 103,1096 412.438
2012-06-12 BIO, BIO.B CRUTCHFIELD BRADFORD 87 96,5100 87 96,5100 8.396
2012-06-11 BIO, BIOB CRUTCHFIELD BRADFORD 89 96,4900 89 96,4900 8.588

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BIO / Bio-Rad Laboratories, Inc. Insider Trades
Insiderkøb TXG / 10x Genomics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BIO / Bio-Rad Laboratories, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-05-13 TXG CRUTCHFIELD BRADFORD 158 40,4855 158 40,4855 6.397 322 55.7900 2.419 37,82

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TXG / 10x Genomics, Inc. Insider Trades
Insidersalg TXG / 10x Genomics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BIO / Bio-Rad Laboratories, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2022-05-23 TXG CRUTCHFIELD BRADFORD 286 48,7642 286 48,7642 13.947 154 24.4000 -6.968 -49,96
2022-02-22 TXG CRUTCHFIELD BRADFORD 288 78,5993 288 78,5993 22.637
2021-11-22 TXG CRUTCHFIELD BRADFORD 281 148,3811 281 148,3811 41.695
2021-08-23 TXG CRUTCHFIELD BRADFORD 270 161,8475 270 161,8475 43.699
2021-05-24 TXG CRUTCHFIELD BRADFORD 281 162,6596 281 162,6596 45.707

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TXG / 10x Genomics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Bradford Crutchfield som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2022-05-25 2022-05-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale -286 97.237 -0,29 48,76 -13.947 4.741.685
2022-05-17 2022-05-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
P - Purchase 158 97.523 0,16 40,49 6.397 3.948.267
2022-02-24 2022-02-22 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale -288 97.365 -0,29 78,60 -22.637 7.652.821
2022-02-17 2022-02-15 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 392.000 -4,16
2022-02-17 2022-02-15 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -17.000 97.653 -14,83 95,13 -1.617.261 9.290.023
2022-02-17 2022-02-15 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 114.653 17,41 1,16 19.720 132.997
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 409.000 -3,99
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3 97.653 0,00 125,00 -375 12.206.625
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 97.656 -0,10 124,44 -12.444 12.152.313
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 97.756 -0,10 123,53 -12.353 12.075.799
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 97.856 -0,10 122,94 -12.294 12.030.417
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.200 97.956 -3,16 121,76 -389.648 11.927.612
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.100 101.156 -1,08 120,93 -133.025 12.232.937
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.017 102.256 -0,98 119,28 -121.311 12.197.443
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5.185 103.273 -4,78 118,32 -613.499 12.219.447
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -6.195 108.458 -5,40 117,53 -728.071 12.746.592
2022-01-14 2022-01-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 114.653 17,41 1,16 19.720 132.997
2021-12-23 2021-12-21 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise -49.910 61.757 -44,70
2021-12-23 2021-12-21 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise -4.688 0 -100,00
2021-12-23 2021-12-21 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise 49.910 97.653 104,54 5,04 251.546 492.171
2021-12-23 2021-12-21 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise 4.688 47.743 10,89 1,20 5.626 57.292
2021-12-15 2021-12-13 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 426.000 -3,84
2021-12-15 2021-12-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 43.055 -0,23 142,47 -14.247 6.134.046
2021-12-15 2021-12-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -800 43.155 -1,82 141,31 -113.049 6.098.276
2021-12-15 2021-12-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.701 43.955 -3,73 140,38 -238.792 6.170.544
2021-12-15 2021-12-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -9.599 45.656 -17,37 139,52 -1.339.239 6.369.861
2021-12-15 2021-12-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.235 55.255 -5,53 138,60 -448.374 7.658.393
2021-12-15 2021-12-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.565 58.490 -2,61 137,63 -215.396 8.050.160
2021-12-15 2021-12-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 60.055 39,48 1,16 19.720 69.664
2021-11-24 2021-11-22 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale -281 43.055 -0,65 148,38 -41.695 6.388.548
2021-11-16 2021-11-12 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 443.000 -3,70
2021-11-16 2021-11-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 43.336 -0,23 168,34 -16.834 7.295.182
2021-11-16 2021-11-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 43.436 -0,23 167,27 -16.727 7.265.540
2021-11-16 2021-11-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -4.776 43.536 -9,89 165,89 -792.306 7.222.326
2021-11-16 2021-11-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -6.872 48.312 -12,45 164,87 -1.132.963 7.965.030
2021-11-16 2021-11-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -4.122 55.184 -6,95 164,18 -676.733 9.059.888
2021-11-16 2021-11-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.030 59.306 -1,71 163,10 -167.994 9.672.886
2021-11-16 2021-11-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 60.336 39,23 1,16 19.720 69.990
2021-10-14 2021-10-12 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 460.000 -3,56
2021-10-14 2021-10-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.043 43.336 -6,56 158,63 -482.716 6.874.455
2021-10-14 2021-10-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -7.997 46.379 -14,71 157,40 -1.258.760 7.300.240
2021-10-14 2021-10-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5.960 54.376 -9,88 156,49 -932.678 8.509.278
2021-10-14 2021-10-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 60.336 39,23 1,16 19.720 69.990
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 477.000 -3,44
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 43.336 -0,23 184,32 -18.432 7.987.692
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 43.436 -0,23 181,24 -18.124 7.872.123
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -500 43.536 -1,14 178,90 -89.451 7.788.677
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.000 44.036 -2,22 178,24 -178.237 7.848.845
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.700 45.036 -3,64 177,21 -301.259 7.980.870
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.906 46.736 -7,71 176,19 -688.198 8.234.411
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.694 50.642 -5,05 175,17 -471.900 8.870.802
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.700 53.336 -4,82 174,14 -470.166 9.287.686
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 56.036 -0,71 172,40 -68.958 9.660.326
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -300 56.436 -0,53 171,20 -51.361 9.662.029
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.300 56.736 -2,24 170,30 -221.394 9.662.334
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.300 58.036 -3,81 169,06 -388.834 9.811.462
2021-09-15 2021-09-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 60.336 39,23 1,16 19.720 69.990
2021-08-25 2021-08-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale -270 43.336 -0,62 161,85 -43.699 7.013.823
2021-08-16 2021-08-12 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 494.000 -3,33
2021-08-16 2021-08-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -800 43.606 -1,80 161,84 -129.472 7.057.195
2021-08-16 2021-08-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5.087 44.406 -10,28 161,28 -820.436 7.161.840
2021-08-16 2021-08-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.400 49.493 -6,43 160,00 -544.011 7.919.038
2021-08-16 2021-08-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.213 52.893 -5,73 159,13 -511.290 8.416.942
2021-08-16 2021-08-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.400 56.106 -4,10 158,07 -379.374 8.868.804
2021-08-16 2021-08-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.100 58.506 -3,47 157,19 -330.100 9.196.576
2021-08-16 2021-08-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 60.606 38,99 1,16 19.720 70.303
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 511.000 -3,22
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -300 43.606 -0,68 191,60 -57.481 8.354.984
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -600 43.906 -1,35 190,86 -114.518 8.380.022
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -500 44.506 -1,11 189,36 -94.682 8.427.834
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.512 45.006 -3,25 188,32 -284.733 8.475.318
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.933 46.518 -7,80 187,31 -736.674 8.713.101
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -4.400 50.451 -8,02 185,87 -817.811 9.377.136
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5.755 54.851 -9,50 185,07 -1.065.097 10.151.461
2021-07-14 2021-07-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 60.606 38,99 1,16 19.720 70.303
2021-06-16 2021-06-14 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 528.000 -3,12
2021-06-16 2021-06-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 43.262 -0,92 193,64 -77.456 8.377.254
2021-06-16 2021-06-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5.100 43.662 -10,46 192,97 -984.128 8.425.290
2021-06-16 2021-06-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -4.500 48.762 -8,45 192,12 -864.535 9.368.102
2021-06-16 2021-06-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.000 53.262 -5,33 191,16 -573.476 10.181.484
2021-06-16 2021-06-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.084 56.262 -5,20 190,01 -585.995 10.690.416
2021-06-16 2021-06-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -916 59.346 -1,52 189,03 -173.147 11.217.907
2021-06-16 2021-06-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 60.262 39,30 1,16 19.720 69.904
2021-05-26 2021-05-24 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale -281 43.262 -0,65 162,66 -45.707 7.036.980
2021-05-26 2021-03-19 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
A - Award 22.338 22.338
2021-05-26 2021-03-19 4 TXG 10x Genomics, Inc.
Class A Common Stock
A - Award 8.935 43.543 25,82
2021-05-13 2021-05-12 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 545.000 -3,02
2021-05-13 2021-05-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 34.608 -0,29 137,57 -13.757 4.761.023
2021-05-13 2021-05-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.200 34.708 -3,34 136,80 -164.164 4.748.169
2021-05-13 2021-05-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.702 35.908 -7,00 135,74 -366.781 4.874.310
2021-05-13 2021-05-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -7.875 38.610 -16,94 134,70 -1.060.759 5.200.752
2021-05-13 2021-05-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5.123 46.485 -9,93 133,86 -685.759 6.222.431
2021-05-13 2021-05-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 51.608 49,12 1,16 19.720 59.865
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 562.000 -2,94
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -300 34.608 -0,86 192,17 -57.652 6.650.734
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.100 34.908 -3,05 190,31 -209.340 6.643.324
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.400 36.008 -3,74 189,34 -265.075 6.817.737
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.398 37.408 -6,02 188,36 -451.695 7.046.287
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.996 39.806 -4,77 187,10 -373.450 7.447.667
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.855 41.802 -6,39 186,31 -531.911 7.788.068
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.500 44.657 -3,25 185,14 -277.714 8.267.918
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -600 46.157 -1,28 184,32 -110.591 8.507.594
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.302 46.757 -2,71 182,75 -237.938 8.544.744
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.642 48.059 -5,21 181,84 -480.426 8.739.140
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -907 50.701 -1,76 181,10 -164.260 9.182.098
2021-04-13 2021-04-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 51.608 49,12 1,16 19.720 59.865
2021-03-16 2021-03-12 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 579.000 -2,85
2021-03-16 2021-03-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.100 34.608 -5,72 159,51 -334.977 5.520.419
2021-03-16 2021-03-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.176 36.708 -7,96 158,85 -504.513 5.831.128
2021-03-16 2021-03-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.211 39.884 -5,25 157,70 -348.684 6.289.866
2021-03-16 2021-03-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.606 42.095 -7,89 156,52 -564.404 6.588.629
2021-03-16 2021-03-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.807 45.701 -7,69 155,54 -592.148 7.108.425
2021-03-16 2021-03-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.100 49.508 -4,07 154,52 -324.492 7.649.966
2021-03-16 2021-03-12 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 51.608 49,12 1,16 19.720 59.865
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 596.000 -2,77
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -200 34.608 -0,57 178,92 -35.783 6.191.890
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -900 34.808 -2,52 177,86 -160.073 6.190.930
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.700 35.708 -7,03 176,94 -477.751 6.318.348
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -8.451 38.408 -18,03 175,94 -1.486.839 6.757.369
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -4.003 46.859 -7,87 175,25 -701.522 8.211.998
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -746 50.862 -1,45 173,99 -129.796 8.849.459
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 51.608 49,12 1,16 19.720 59.865
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 613.000 -2,70
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 34.608 -1,14 141,77 -56.708 4.906.376
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.135 35.008 -8,22 140,74 -441.211 4.926.928
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -10.465 38.143 -21,53 139,89 -1.463.947 5.335.817
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.000 48.608 -5,81 138,97 -416.908 6.755.015
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 51.608 49,12 1,16 19.720 59.865
2020-12-30 2020-12-28 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise -13.333 111.667 -10,67
2020-12-30 2020-12-28 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise -20.312 4.688 -81,25
2020-12-30 2020-12-28 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise 13.333 34.608 62,67 5,04 67.198 174.424
2020-12-30 2020-12-28 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise 20.312 21.275 2.109,24 1,20 24.374 25.530
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 630.000 -2,63
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.718 963 -64,08 153,58 -263.852 147.899
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.410 2.681 -47,34 152,96 -368.628 410.080
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.295 5.091 -31,07 151,68 -348.096 772.183
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5.496 7.386 -42,66 150,87 -829.161 1.114.298
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5.081 12.882 -28,29 150,02 -762.245 1.932.540
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 17.963 1.765,32 1,16 19.720 20.837
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -6.496 647.000 -0,99
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -200 963 -17,20 138,43 -27.686 133.308
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.898 1.163 -77,02 137,56 -536.203 159.980
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.198 5.061 -30,28 136,60 -300.255 691.351
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -200 7.259 -2,68 135,42 -27.084 983.014
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 6.496 7.459 674,56 1,16 7.535 8.652
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -10.504 653.496 -1,58
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 963 -29,35 139,24 -55.698 134.093
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -800 1.363 -36,99 138,40 -110.719 188.638
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.200 2.163 -35,68 136,97 -164.361 296.260
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -6.604 3.363 -66,26 136,06 -898.572 457.586
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.500 9.967 -13,08 135,29 -202.938 1.348.455
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10.504 11.467 1.090,76 1,16 12.185 13.302
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 664.000 -2,50
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -300 963 -23,75 126,88 -38.064 122.185
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.475 1.263 -73,34 125,99 -437.822 159.128
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -10.725 4.738 -69,36 125,48 -1.345.731 594.506
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.500 15.463 -13,92 124,26 -310.643 1.921.389
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 17.963 1.765,32 1,16 19.720 20.837
2020-09-03 2020-09-02 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -3.224 681.000 -0,47
2020-09-03 2020-09-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -50 963 -4,94 114,89 -5.744 110.639
2020-09-03 2020-09-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -150 1.013 -12,90 114,10 -17.115 115.583
2020-09-03 2020-09-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -528 1.163 -31,22 113,18 -59.759 131.628
2020-09-03 2020-09-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.496 1.691 -46,94 112,32 -168.035 189.938
2020-09-03 2020-09-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.000 3.187 -23,88 111,33 -111.327 354.800
2020-09-03 2020-09-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 3.224 4.187 334,79 1,16 3.740 4.857
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -13.776 684.224 -1,97
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -500 963 -34,18 115,41 -57.704 111.139
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -4.789 1.463 -76,60 114,65 -549.039 167.727
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5.887 6.252 -48,50 113,82 -670.067 711.611
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.600 12.139 -17,64 112,92 -293.593 1.370.741
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 13.776 14.739 1.430,53 1,16 15.980 17.097
2020-08-05 2020-08-03 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 698.000 -2,38
2020-08-05 2020-08-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.200 963 -55,48 100,72 -120.859 96.989
2020-08-05 2020-08-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -8.342 2.163 -79,41 99,47 -829.818 215.164
2020-08-05 2020-08-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -7.458 10.505 -41,52 98,94 -737.930 1.039.414
2020-08-05 2020-08-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 17.963 1.765,32 1,16 19.720 20.837
2020-07-02 2020-07-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 715.000 -2,32
2020-07-02 2020-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -500 0 -100,00 88,73 -44.366
2020-07-02 2020-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -8.900 500 -94,68 87,94 -782.708 43.972
2020-07-02 2020-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -7.600 9.400 -44,71 87,11 -662.062 818.866
2020-07-02 2020-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 17.000 1,16 19.720 19.720
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 732.000 -2,27
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.000 0 -100,00 81,92 -163.844
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -4.900 2.000 -71,01 81,39 -398.801 162.776
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.500 6.900 -26,60 80,05 -200.132 552.364
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.500 9.400 -21,01 79,14 -197.845 743.897
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.400 11.900 -22,22 78,06 -265.420 928.969
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.700 15.300 -10,00 77,17 -131.182 1.180.638
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 17.000 1,16 19.720 19.720
2020-05-05 2020-05-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 749.000 -2,22
2020-05-05 2020-05-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -300 0 -100,00 79,23 -23.769
2020-05-05 2020-05-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -4.200 300 -93,33 78,66 -330.370 23.598
2020-05-05 2020-05-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -3.695 4.500 -45,09 77,57 -286.634 349.080
2020-05-05 2020-05-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -8.805 8.195 -51,79 76,63 -674.696 627.954
2020-05-05 2020-05-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 17.000 1,16 19.720 19.720
2020-04-23 2020-04-21 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
A - Award 90.667 90.667
2020-04-03 2020-04-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 766.000 -2,17
2020-04-03 2020-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 0 -100,00 59,62 -23.848
2020-04-03 2020-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -7.789 400 -95,12 58,33 -454.318 23.331
2020-04-03 2020-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -8.811 8.189 -51,83 57,75 -508.840 472.919
2020-04-03 2020-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 17.000 1,16 19.720 19.720
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X -17.000 783.000 -2,12
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -41 0 -100,00 70,35 -2.884
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5.800 41 -99,30 69,10 -400.777 2.833
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -546 5.841 -8,55 68,19 -37.230 398.277
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -600 6.387 -8,59 66,85 -40.112 426.992
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.200 6.987 -14,66 65,71 -78.855 459.133
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.513 8.187 -15,60 64,78 -98.009 530.336
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -5.110 9.700 -34,50 63,69 -325.477 617.833
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -2.190 14.810 -12,88 62,62 -137.133 927.368
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 17.000 17.000 1,16 19.720 19.720
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other 70.000 70.000
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other -70.000 0 -100,00
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other 125.000 125.000
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other -125.000 0 -100,00
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other 25.000 25.000
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other -25.000 0 -100,00
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other 800.000 800.000
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other -800.000 0 -100,00
2014-06-11 2014-06-10 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
M - Exercise -240 0 -100,00
2014-06-11 2014-06-10 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
F - Taxes -90 5.332 -1,66 121,96 -10.976 650.291
2014-06-11 2014-06-10 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 240 5.422 4,63
2014-01-03 2014-01-01 4 NSTG NanoString Technologies Inc
Stock Option (Right to Buy)
A - Award 5.847 5.847
2013-11-19 2013-11-15 4 BIO, BIOB BIO RAD LABORATORIES INC
Non-Qualified Stock Option (right to buy)
M - Exercise -4.000 0 -100,00
2013-11-19 2013-11-15 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
F - Taxes -2.592 7.146 -26,61 123,24 -319.376 880.735
2013-11-19 2013-11-15 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 4.000 9.738 69,71 53,75 215.000 523.418
2013-11-05 2013-11-04 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
M - Exercise -240 720 -25,00
2013-11-05 2013-11-04 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 240 7.223 3,44
2013-09-13 2013-09-12 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
M - Exercise -240 960 -20,00
2013-09-13 2013-09-12 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 240 6.983 3,56
2013-09-13 2013-09-11 4 BIO, BIOB BIO RAD LABORATORIES INC
Non-Qualified Stock Option (right to buy)
A - Award 3.200 3.200
2013-09-13 2013-09-11 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
A - Award 1.200 1.200
2013-09-10 2013-09-08 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
M - Exercise -240 480 -33,33
2013-09-10 2013-09-08 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 240 6.743 3,69
2013-06-27 2013-06-25 4 NSTG NanoString Technologies Inc
Stock Option (Right to Buy)
A - Award 11.686 11.686
2013-06-25 3 NSTG NanoString Technologies Inc
No securities are beneficially owned
0
2013-06-11 2013-06-10 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
M - Exercise -240 240 -50,00
2013-06-11 2013-06-10 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 240 6.503 3,83
2012-11-06 2012-11-04 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
M - Exercise -240 960 -20,00
2012-11-06 2012-11-04 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 240 6.263 3,98
2012-09-14 2012-09-12 4 BIO, BIOB BIO RAD LABORATORIES INC
Non-Qualified Stock Option (right to buy)
A - Award 3.250 3.250
2012-09-14 2012-09-12 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
A - Award 1.200 1.200
2012-09-11 2012-09-10 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
S - Sale -92 6.023 -1,50 103,49 -9.521 623.323
2012-09-11 2012-09-08 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
M - Exercise -240 720 -25,00
2012-09-11 2012-09-08 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 240 6.115 4,09
2012-08-21 2012-08-20 4 BIO, BIOB BIO RAD LABORATORIES INC
Non-Qualified Stock Option (right to buy)
M - Exercise -1.130 0 -100,00
2012-08-21 2012-08-20 4 BIO, BIOB BIO RAD LABORATORIES INC
Incentive Stock Option (right to buy)
M - Exercise -2.870 0 -100,00
2012-08-21 2012-08-20 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
S - Sale -4.000 5.875 -40,51 103,11 -412.438 605.769
2012-08-21 2012-08-20 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 4.000 9.875 68,09 35,50 142.000 350.562
2012-06-13 2012-06-12 4 BIO, BIO.B BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
S - Sale -87 5.875 -1,46 96,51 -8.396 566.996
2012-06-12 2012-06-11 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
S - Sale -89 5.962 -1,47 96,49 -8.588 575.273
2012-06-12 2012-06-10 4 BIO, BIOB BIO RAD LABORATORIES INC
Restricted Stock Units
M - Exercise -240 480 -33,33
2012-06-12 2012-06-10 4 BIO, BIOB BIO RAD LABORATORIES INC
Bio-Rad A Common Stock
M - Exercise 240 6.051 4,13
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)